Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Kyntra Bio Inc., 3 years.
Kyntra Bio Inc.
Director
Xilio Therapeutics Inc.
Director
Climb Bio Inc.
Director · President and CEO
Chief executive roles
Climb Bio Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 29, 2026 | Climb Bio Inc. | Open-market sale | −30,902 | $13.17 | $406,979 |
| Jun 27, 2026 | Climb Bio Inc. | Option exercise | +68,750 | — | — |
| Jun 30, 2025 | Climb Bio Inc. | Open-market sale | −20,618 | $1.22 | $25,154 |
| Jun 27, 2025 | Climb Bio Inc. | Option exercise | +68,750 | — | — |
| Jun 9, 2023 | Kyntra Bio Inc. | Open-market sale | −1,994 | $16.74 | $33,380 |
| Jun 9, 2023 | Kyntra Bio Inc. | Open-market sale | −2,739 | $17.52 | $47,987 |
| Jun 7, 2023 | Kyntra Bio Inc. | Grant or award | +8,289 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.